UNSPSC 85722167: Fusion of left metatarsal-tarsal joint with synthetic substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to fusion of left metatarsal-tarsal joint with synthetic substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0SGL3JZ

UNSPSC 85722167 (Fusion of left metatarsal-tarsal joint with synthetic substitute, percutaneous approach) is a Commodity code that shows no relevant recent state and local procurement activity. The code nominally describes a specific orthopedic surgical procedure, yet the six recent state and local opportunities posted under this code are unrelated to surgical implants or orthopedic joint fusion. Instead, they solicit independent medical evaluation services, pharmacy benefit management, health professional staffing, occupational medical surveillance, surgical care networks, and specialty medical services for detained youth — none of which align with the procurement or supply of fusion implants or surgical devices. The mismatch between the code's clinical descriptor and the actual goods or services being bought suggests either misclassification in the posting system or that this code does not meaningfully represent current state and local purchasing patterns for the product it nominally describes.

The opportunities that have been tagged to this code span multiple issuing bodies — city retirement offices (Phoenix), county health systems (Santa Clara, Harris County), county procurement offices (Collier County), state transportation departments (Washington State Department of Transportation), and city employee benefits programs (Long Beach) — but none procure the joint fusion procedure or related surgical implants the code names. Geographic spread includes California, Arizona, Florida, Texas, and Washington, with posting dates between July and September 2026. Without relevant recent opportunities under this code, there is no actionable signal for vendors supplying fusion implants or related orthopedic surgical hardware.